Inventor
GALL ALEXANDER
US13 patents
⚠️ This page may combine multiple inventors who share the name “GALL ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KORONIS PHARMACEUTICALS INC
7 patentsUS7642247B2Jan 5, 2010
1,3,5-triazines for treatment of viral diseases
KORONIS PHARMACEUTICALS INC27 citations90
US7244732B2Jul 17, 2007
Prodrugs of heteroaryl compounds
KORONIS PHARMACEUTICALS INC9 citations71
US7648967B2Jan 19, 2010
Mutagenic nucleoside analogs for the treatment of viral disease
KORONIS PHARMACEUTICALS INC2 citations61
US7244717B2Jul 17, 2007
Mutagenic nucleoside analogs for the treatment of viral disease
KORONIS PHARMACEUTICALS INC2 citations61
US7982034B2Jul 19, 2011
Prodrugs of heteroaryl compounds
KORONIS PHARMACEUTICALS INC2 citations60
US7772197B2Aug 10, 2010
1,3,5-triazines for treatment of viral diseases
KORONIS PHARMACEUTICALS INC3 citations60
US7589092B2Sep 15, 2009
Prodrugs of heteroaryl compounds
KORONIS PHARMACEUTICALS INC3 citations60
CEPHEID
3 patentsUS11807643B2Nov 7, 2023
Fluorescent dyes
CEPHEID0 citations51
US12071547B2Aug 27, 2024
Sulforhodamine phosphoramidite dyes
CEPHEID0 citations50
US11603555B2Mar 14, 2023
Integrated purification and measurement of DNA methylation and co-measurement of mutations and/or MRNA expression levels in an automated reaction cartridge
CEPHEID0 citations46
EPOCH PHARMACEUTICALS INC
2 patentsUS6143877ANov 7, 2000
Oligonucleotides including pyrazolo[3,4-D]pyrimidine bases, bound in double stranded nucleic acids
EPOCH PHARMACEUTICALS INC81 citations95
US5659022AAug 19, 1997
Oligonucleotide-cyclopropapyrroloindole conjugates as sequence specific hybridization and crosslinking agents for nucleic acids
EPOCH PHARMACEUTICALS INC33 citations92